SAIPARENT
Sai Parenterals Limited
Pharmaceuticals
Share price
₹492
Market cap
₹2,178 Cr
1Y return
▲ 21%
A diversified pharmaceutical formulations company, Sai Parenteral's specializes in the research, development, and manufacturing of injectable and parenteral drugs for multiple therapeutic areas. Incorporated in 2001, the company maintains expertise in complex formulation technologies and operates integrated manufacturing facilities. It serves both domestic and international markets, with a focus on quality compliance and advanced pharmaceutical solutions across its product portfolio.
Investors holding Sai Parenterals Limited
Recent moves 5
Morgan StanleyExited
Morgan Stanley's name is missing from Sai Parenterals Limited's latest shareholder list, down from a 1.17 percent stake. This shift represents either a complete exit or a reduction to just under the 1 percent reporting threshold.
Read more
Quant Mutual FundExited
Quant Mutual Fund, which previously held a 3.81 percent stake in Sai Parenterals Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction of its holding to below the 1 percent reporting requirement.
Read more
Astorne CapitalExited
Astorne Capital, which previously held a 1.15 percent stake in Sai Parenterals Limited, is no longer listed among its public shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.
Read more
Kotak Mahindra Life InsuranceDecreased
Kotak Mahindra Life Insurance reduced its stake in Sai Parenterals Limited from 2.89% to 2.35% by selling 2,35,180 shares.
Read more
Morgan StanleyNew position
Morgan Stanley acquired 514,798 shares, a 1.17% stake in Sai Parenterals Limited. Morgan Stanley Asia (Singapore) Pte Ltd was an anchor investor in the Sai Parenterals IPO in March 2026.
Read more
Track the whales in Sai Parenterals Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1